Transposed basilic vein versus polytetrafluorethylene for brachial- axillary arteriovenous fistulas

American Journal of Surgery

Volumn 176, Issue 2, 1998, Pages 219-221

  Matsuura, John H ^b   Rosenthal, David ^b   Clark, Michael ^b   Shuler, Frederick W ^b   Kirby, Lem ^b   Shotwell, Michael ^b   Purvis, Jerry ^b   Pallos, L Laszlo ^a  

^a AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

POLITEF;

ADULT; ARTERIOVENOUS FISTULA; AXILLARY VEIN; BRACHIAL ARTERY; CONFERENCE PAPER; FEMALE; GRAFT INFECTION; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; RISK FACTOR; SURGICAL TECHNIQUE; VASCULAR ACCESS; VEIN GRAFT;

ARTERIOVENOUS SHUNT, SURGICAL; AXILLARY VEIN; BRACHIAL ARTERY; FEMALE; FOREARM; HAND; HUMANS; MALE; MIDDLE AGED; POLYTETRAFLUOROETHYLENE; RISK FACTORS; TIME FACTORS; VASCULAR PATENCY; VEINS;

EID: 0032143559     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(98)00122-6     Document Type: Conference Paper

References (11)

1. 1. Kolff WJ, Berk HT. The artificial kidney: a dialyser with a great area. Acta Med Scand. 1944;117:121-131.
2. 2. Hirth RA, Turenne MN, Woods JD, et al. Geographic and demographic variations in vascular access. In: Henry ML, Ferguson RM, eds. Vascular Access For Hemodialysis. 5th ed. Tucson: W.L. Gore and Precept Press; 1997:22-31.
3. 3. Brescia MJ, Cimino JE, Appel K, Hurwich BJ. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. NEJM. 1966;275:1089-1092.
4. 4. Elcheroth J, DePauw L, Kinnaert P. Elbow arteriovenous fistulas for chronic haemodialysis. Br J Surg. 1994;81:982-984.
5. 5. Dagher F, Gelber R, Ramos E, Sadler J. The use of basilic vein and brachial artery as an AV fistula for long-term hemodialysis. J Surg Res. 1976;20:373-376.
6. 6. LoGerfo FW, Menzoian JO, Kumaki DJ, Idelson BA. Transposed basilic vein-brachial arteriovenous fistula: a reliable secondary-access procedure. Arch Surg. 1978;113:1008-1010.
7. 7. Rivers SP, Scher LA, Sheehan E, et al. Basilic vein transposition: an underused autologous alternative to prosthetic dialysis angioaccess. J Vasc Surg. 1993;18:391-397.
8. 8. Rutherford RB, Flanigan DP, Gupta SK, et al. Suggested standards for reports dealing with lower extremity ischemia. Prepared by the Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg. 1986;4:80-94.
9. 9. Palder SB, Kirkman RL, Whittemore AD, et al. Vascular access for hemodialysis: patency rates and results of revision. Ann Surg. 1985;202:235-239.
10. 10. Miller A, Holzenbein TJ, Gottlieb MN, et al. Strategies to increase the use of autogenous arteriovenous fistula in end stage renal disease. Ann Vasc Surg. 1997;11:397-405.
11. 11. Coburn MC, Carney WI. Comparison of basilic vein and polytetrafluoroethylene for brachial arteriovenous fistula. J Vasc Surg. 1994;20:896-904.